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Abstract
Acute eosinophilic pneumonia (AEP) is characterized by an acute onset respiratory illness with bilateral chest infiltrates and evi-
dence of pulmonary eosinophilia. Cigarette smoking is the main risk factor, but drugs and other inhalational exposures have also 
been reported. Herein, the association between AEP and smoking devices other than cigarettes is reviewed
The PubMed database was searched using terms such as ”smoking”, ”vaping”, ”e-cigarette”, ”waterpipe”, and ”marijuana”, 
along with other commonly used synonyms for these terms. In addition, eosinophilic lung diseases were also searched for using 
the same database. All cases of AEP were identified using the modified Philit criteria in association with the use of marijuana, 
waterpipe, e-cigarettes or heat-not-burn cigarettes. Cases associated with illicit drug use were excluded.
Twelve cases were included with a median age of 20 (15–60). 75% of patients studied were male. Exposures included marijuana 
smoking (n = 5), waterpipe usage (n = 2), heat-not-burn cigarette use (n = 2), e-cigarette use (n = 2) and synthetic cannabinoid 
use (n = 1). A recent change in smoking habits was reported in 50% of patients. Presenting symptoms were dyspnea (91.6%), 
cough (66.6%), fever (66.6%) and chest pain (25%). 90% of patients had leukocytosis on presentation, but only 16.6% had peri-
pheral eosinophilia. The median eosinophil percentage in bronchoalveolar lavage was 67.5% (0 to 78). Two patients had a lung 
biopsy performed. Bilateral involvement on chest imaging was reported in all patients. Five patients (41.6%) required invasive 
mechanical ventilation and ten patients (83.3%) were treated in an intensive care unit. All patients responded to corticosteroid 
therapy with no relapses reported.  
Acute eosinophilic pneumonia is reported with smoking that does not include traditional cigarette smoking such as waterpipes, 
e-cigarettes, heat-not-burn cigarettes, and marijuana and can have a similar presentation and clinical course. 
Key words: eosinophilic pneumonia, smoking, e-cigarette, waterpipe, vaping, marijuana, cannabis
Adv Respir Med. 2020; 88: 142–146
Introduction
Acute eosinophilic pneumonia (AEP) is an 
eosinophilic lung disease characterized by an 
acute onset febrile respiratory illness with bron-
choalveolar lavage eosinophilia that promptly 
responds to treatment with steroids. While the 
disease can be idiopathic, cigarette smoking is 
a major risk factor [1, 2] and commonly occurs in 
the setting of new exposure or a recent change in 
smoking habits [3, 4]. Drug use and other inha-
lational exposures are also known triggers [5–7]. 
Here, the reported cases of AEP in association 
with non-cigarette smoking such as e-cigarette, 
marijuana, and waterpipe smoking are reviewed. 
Material and methods
The PubMed database was searched using the 
following keywords: smoking, electronic nicotine 
delivery systems, waterpipe, hookah, shisha, ma-
rijuana, cannabis, non-cigarette tobacco, vaping, 
e-cigarettes, electronic cigarettes and cannabis 
sativa. These keywords were searched for in 
combination with the following medical com-
plications: eosinophilic pneumonia, respiratory 
distress syndrome, ARDS, respiratory insufficien-
cy, and  pulmonary eosinophilia. The “Related 
articles” section in PubMed was used to screen 
for additional relevant articles. The reference lists 
of the relevant articles were also screened to look 
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for other manuscripts eligible for the current re-
view. Cases were included if they involved cases 
of AEP defined as: 1) Acute respiratory illness of 
1-month duration or less; 2) Bilateral pulmona-
ry infiltrates on chest imaging; 3) Eosinophilic 
pneumonia detected by Bronchoalveolar lavage 
(BAL) with eosinophils totaling more than 25% or 
showing eosinophilic pneumonia on lung biopsy. 
In addition, exposure to smoking items other than 
traditional cigarettes was required and included 
cannabis, electronic cigarettes, heat-not-burn 
cigarettes, waterpipes and hookahs. Cases with 
exposure to illicit drug use were excluded. The 
results of this search are summarized in Figure 
1. 943 abstracts were reviewed and 42 of them 
were identified for full text review (in addition 
to one relevant report identified by screening the 
references of the reviewed articles). Two were 
excluded because of illicit drug use exposure 
and 29 articles were not relevant (review articles 
or no relevant exposure). Twelve cases met the 
inclusion criteria (Figure 1). 
Results
Patient characteristics and exposures
Table 1 summarizes the reported cases and 
patient demographics. 12 cases of AEP linked to 
non-cigarette smoking were reported with the 
patients having a median age of 20 (range 15–60). 
42.6% were younger or equal to 18 years of age 
and 75% were male. Exposures reported included 
patients who smoked marijuana (n = 5), used 
a waterpipe (n = 2), smoked heat-not-burn ciga-
rettes (n = 2), used e-cigarettes (n = 2), and one 
who used synthetic cannabinoids (n = 1). 25% 
reported associated cigarette smoking. A recent 
change in smoking habits was reported in 50% of 
patients and included the following: new initia-
tion within 1 month in one patient, recent product 
change in four patients, and restarting less than 
1 month in 3 patients. One patient also reported 
starting cigarette smoking within 1 month of 
symptom onset. Time from the last inhalational 
exposure to onset of symptoms was reported in 
5 cases; three of them occurred within 1 day, 
one occurred after 2 days, and one occurred after 
2 weeks. Two patients reported comorbid asthma. 
Clinical manifestations, laboratory and 
radiological findings
Patients presented with dyspnea (91.6%), cough 
(66.6%), fever (66.6%) and chest pain (25%). Lung 
auscultation findings were reported in 9 out of 
12 patients and findings included crackles (55.5%) 
and wheezing (22.2%). White blood cell count 
(WBCs) was reported in 11 patients with a median 
of 19,95 × 109/L (range 5.8 to 28) with 90% having 
leukocytosis as defined by WBC count greater 
than 11 × 109 cells/L. Only 2 patients (16.6) had 
peripheral eosinophilia on presentation. Three 
additional patients (25%) developed peripheral 
eosinophilia during their hospitalization. 
Bronchoalveolar lavage eosinophil cell count 
was reported in 11 out of 12 patients. In one of 
the patients, the procedure had to be aborted due 
to hypoxemia which resulted in an inadequate 
sample. Of the remaining ten patients, the median 
eosinophil percentage was 67.5% (range 0 to 78) 
with 90% of patients having an eosinophil count 
totaling more than 25%. The only patient who 
had less than 25% (0 eosinophils) was treated 
with corticosteroids prior to bronchoscopy. One 
patient’s sputum was sent for evaluation and 
their eosinophil count was 14%. IgE levels were 
reported in 4 patients; they were normal in three 
patients and elevated in one. Lung biopsies were 
obtained in two patients and confirmed eosino-
philic pneumonia. One of these biopsies was 
conducted using video assisted thoracoscopic 
surgery (VATS), while the other sampling method 
was not specified.
Bilateral involvement on chest imaging was 
reported in all patients. Computed tomography 
1 record identified 
through other 
sources
943 records 
identified through 
PubMed
944 records 
screened
901 not related
43 full text articles 
assessed
31 excluded
29 (review articles, 
not AEP)
12 articles met 
inclusion criteria
2 with illicit 
drug use
Figure 1. Study flowchart
AEP — acute eosinophilic pneumonia
Advances in Respiratory Medicine 2020, vol. 88, no. 2, pages 142–146
144 www.journals.viamedica.pl
Table 1. Articles reviewed and patient characteristics
Publication Exposure Study design Number of patients 
with AEP
Age Gender Current cigarette
smoker
Sauvaget et al. 2010 [8] Marijuana Case report 1 15 M Yes
Liebling et al. 2013 [9] Marijuana Case report 1 60 M No
Natarajan et al. 2013 [10] Marijuana Case report 1 29 M Yes
Dyal et al. 2014 [11] Hookah Case report 1 26 F No
Thota et al. 2014 [12] E-cigarette Case report 1 20 M No
Kang et al. 2016 [13] Hookah Case report 1 NA M No
Kamada et al. 2016 [14] Heat not burn Case report 1 20 M No
Schlossma et al. 2017 
[15]
Synthetic canna-
binoids inhaled
Case report/ 
/poster presentation
1 18 F No
McElligott et al. 2017 [16] Marijuana Case report/ 
/poster presentation
1 20 M Yes
McGraw et al. 2018 [17] Marijuana Case series 1 17 M No
Aokage et al. 2019 [18] Heat not burn Case report 1 16 M No
Arter et al. 2019 [19] E-cigarette Case report 1 18 F No
AEP — acute eosinophilic pneumonia
Table 2. Computed tomography (CT) of the chest findings
CT chest findings N (%)
Ground glass opacities 7 (58)
Consolidation/infiltrates 6 (50)
Nodules/nodular infiltrates 2 (16.6)
Interlobular septal thickening 3 (25)
Tree in bud 1 (8.3)
Pleural effusions 4 (33.3)
of the chest (CT chest) findings are summarized 
in Table 2. 
Treatment and outcomes
Two patients (16.6%) did not require respi-
ratory support, two patients (16.6%) required 
supplemental oxygen therapy, 1 patient (8.3%) 
was treated with noninvasive positive pressure 
ventilation, and 5 patients (41.6%) required inva-
sive mechanical ventilation. One patient required 
extracorporeal membrane oxygenation (ECMO) 
and another patient was transferred for ECMO 
to another institution. Ten patients (83.3%) were 
treated in an intensive care unit. All patients 
received corticosteroids with varying regimens 
with five of them  (41.6%) receiving oral cortico-
steroids. All patients responded to steroid therapy 
with no relapses reported.  
Discussion
Acute eosinophilic pneumonia is a disease 
characterized by an acute respiratory illness 
with bilateral involvement on chest imaging, 
pulmonary eosinophilia and a prompt response 
to treatment with corticosteroids. It commonly 
progresses to respiratory failure requiring inva-
sive mechanical ventilation and intensive care 
[1, 4, 20]. Philit et al. [21] suggested diagnostic 
criteria which required subsequent modifications 
[1, 4] seeing as hypoxemia is not present in all 
patients and recovery without steroids was repor-
ted. Cigarette smoking is a strong risk factor [1, 
2] and patients frequently report recent initiation 
of smoking, a change in smoking habits [3, 4], 
drug use and/or other inhalational exposures [5, 
6, 22, 23]. Non-cigarette forms of smoking are 
increasingly used. These include e-cigarettes 
[24, 25], waterpipe/hookah smoking [25–27], 
and marijuana use [28]. Younger populations are 
mainly at risk and include adolescents as well 
as college and university students [26, 29–31]. 
Recently, an outbreak of vaping induced lung 
injury was reported [32]. Other pulmonary effects 
of vaping include: bronchial toxicity [33], lipoid 
pneumonia [34], diffuse alveolar hemorrhage [35], 
hypersensitivity pneumonitis [36], and organizing 
pneumonia [37]. In the current review, literature 
was researched for reported cases of AEP associa-
ted with these exposures. The median age in the 
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reviewed cases was 20 with 42% being 18 years 
of age or younger. This reflects the increasing 
use of such products by the young and adole-
scent population, and the need for public health 
policies and awareness to address this problem 
as they are frequently falsely perceived as safe 
by the public. In addition to the direct health 
consequences of these products, they increase 
the risk of traditional cigarette smoking in users 
[38]. As reported by Rhee et al. [4], the exposure 
to other types of smoking was frequently recently 
started or altered (50% of patients) similarly to 
traditional cigarette smokers. Fever was present 
in 66.6% of the patients, but higher percentages 
were reported in other studies (mean 80%) [1]. 
Peripheral eosinophilia was not common during 
presentation and this is a related finding to Gia-
comi et al. [5] who reported a lower incidence of 
peripheral eosinophilia in smoking associated 
AEP (36%) compared to other causes. Cigarette 
smoking and other types of smoking likely share 
common pathophysiological mechanisms which 
might explain why peripheral eosinophilia was 
uncommon upon presentation in this review 
similarly to smoking associated AEP. Like in other 
studies [1, 20], peripheral eosinophilia can arise 
during hospitalization (25% in the reviewed cases 
above). Bronchoalveolar lavage eosinophilia was 
present in most of the reviewed cases. One patient 
had no eosinophils on BAL, but the diagnosis of 
eosinophilic pneumonia was later confirmed by 
biopsy. In this patient, the BAL was done after 
corticosteroid therapy. In another patient, the 
procedure had to be aborted due to hypoxemia. 
The retrieved sample had an eosinophil count 
of 6% and biopsy obtained by VATS confirmed 
eosinophilic pneumonia but the sample was 
deemed ineligible due to the aforementioned 
complication during the procedure. One pa-
tient had sputum cytology showing eosinophilia 
without a reported BAL and responded promptly 
to corticosteroid therapy. Like other studies [1, 
4], ground glass opacities (GGO) and bilateral 
infiltrates were the most common chest imaging 
findings. Pleural effusions were less common in 
the reviewed cases. Some radiological details 
might have been missed from the case reports. 
Invasive mechanical ventilation was required in 
41.6% of patients. One patient required ECMO. 
Rates of mechanical ventilation are lower in AEP 
studies (mean 25%) [1]. This review included 
only case reports where there was a possibility 
of reporting bias where severe cases are reported 
more than milder ones. Different corticosteroid 
regimens were used with an excellent response 
in all patients. The regimens used varied and no 
conclusions can be drawn from these cases, but 
prior data in AEP associated with other causes 
showed that treatment duration could potentially 
be shortened to 2 weeks [4]. This review is limi-
ted by the quality of data available that comes 
mainly from case reports. Clinical, radiological 
and laboratory details might have been omitted. 
Also, reporting bias cannot be excluded as the 
exposure is sometimes not disclosed by patients. 
Conclusion
AEP is reported with smoking outside of 
traditional cigarette smoking including vaping, 
waterpipe smoking, marijuana and HNBCs. The 
disease has a similar presentation and clinical 
course to AEP associated with cigarette smoking 
and other exposures. 
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